ImmunityBio
IBRX
IBRX
180 hedge funds and large institutions have $256M invested in ImmunityBio in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 41 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 31
34% less capital invested
Capital invested by funds: $390M → $256M (-$134M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
180
Holding in Top 10
–
Calls
$18.7M
Puts
$10.9M
Top Buyers
| 1 | +$11.4M | |
| 2 | +$6.24M | |
| 3 | +$4.13M | |
| 4 |
Millennium Management
New York
|
+$3.81M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.94M |
Top Sellers
| 1 | -$6.03M | |
| 2 | -$1.28M | |
| 3 | -$1.26M | |
| 4 |
MASUI
MIRAE ASSET SECURITIES (USA) INC.
New York
|
-$726K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$666K |